In an infection-induced lymphedema study, SOCS1 was identified to be regulated by VEGF-C/VEGFR-3 and its expression inhibited the Toll-like receptor (TLR)-NF-κB signaling, an important pathway that prevents uncontrolled inflammation during bacterial infection (Zhang et al., 2014). This evidence concerns the gene FLT4 and lymphedema.